Thermo Fisher Scientific’s PPD clinical research business named Clinical Research Company of the Year at PharmaTimes International competition
PPD™ clinical research business recognized for global clinical trial excellence and award-winning research teams
Summary:
- Thermo Fisher Scientific’s PPD™ clinical research business named “Clinical Research Company of the Year” at the 2026 PharmaTimes International competition, marking its sixth win in the last seven years
- Recognition highlights the strength of the company’s global clinical research organization and operational excellence across clinical development
- Colleagues across Clinical Operations and Functional Service Partnership (FSP) teams earned gold, silver and bronze honors in multiple individual and team categories
- Award-winning teams represented six countries, reinforcing Thermo Fisher’s global expertise in clinical trial delivery and patient-focused research
WALTHAM, Mass., (June 1, 2026) – The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been recognized for excellence in clinical research at the 2026 PharmaTimes International Clinical Researcher of the Year competition.
The business earned the competition’s top honor, “Clinical Research Company of the Year,” recognizing the strength and expertise of its global clinical research organization.
In addition to the overall company recognition, colleagues across the clinical research business received multiple individual and team awards spanning several categories, including aspiring and junior clinical research associate, clinical research associate, startup individual and clinical research team.
Award winners represented teams across Clinical Operations and Functional Service Partnership (FSP) Solutions and countries including Kenya, Poland, South Africa, Switzerland, France and Australia.
“We are incredibly proud of our colleagues and teams recognized through this year’s PharmaTimes International Clinical Researcher of the Year competition,” said Sebastian Pacios, senior vice president and president, clinical research, Thermo Fisher Scientific. “These awards reflect the dedication, expertise and collaboration our teams bring every day to help accelerate clinical research for customers and ultimately improve patient outcomes around the world.”
Among the honors received:
- Gold recognition in the Aspiring and Junior CRA category
- Gold recognition for Clinical Research Team
- Multiple silver and bronze recognitions across individual and team categories
The PharmaTimes International Clinical Researcher of the Year competition is designed to benchmark clinical research competencies through a rigorous multi-stage evaluation process led by experienced industry judges.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Media Contact:
Kyla O’Brien
Clinical Research, Thermo Fisher Scientific
kyla.obrien@thermofisher.com